PART I Overview Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat conditions, including cancer, inflammation, and autoimmune disease. We believe our asset and royalty aggregation strategy differentiates us from other biotechnology companies because it provides us with an opportunity to optimize future milestone and royalty...
Q2 FY2026 — expected 2026-09-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-02 | 2025-12-31 | 0001937653-26-000015 | EDGAR | 115K words |
| 2025-03-05 | 2024-12-31 | 0001937653-25-000014 | EDGAR | — |
| 2024-03-06 | 2023-12-31 | 0001937653-24-000019 | EDGAR | — |
| 2023-03-07 | 2022-12-31 | 0001937653-23-000011 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001937653-26-000047 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001937653-25-000077 | EDGAR | 65K words |
| 2025-08-07 | 2025-06-30 | 0001937653-25-000049 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001937653-25-000027 | EDGAR | — |
| 2024-10-31 | 2024-09-30 | 0001937653-24-000050 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001937653-24-000041 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0001937653-24-000028 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001937653-23-000037 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001937653-23-000028 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0001937653-23-000018 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001937653-22-000009 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001937653-26-000046 | EDGAR | — |
| 2026-04-01 | 0001193125-26-135610 | EDGAR | 12K words |
| 2026-03-02 | 0001193125-26-084082 | EDGAR | — |
| 2026-03-02 | 0001937653-26-000013 | EDGAR | — |
| 2026-01-12 | 0001193125-26-010480 | EDGAR | — |
| 2025-12-30 | 0001193125-25-337268 | EDGAR | — |
| 2025-11-18 | 0001193125-25-285259 | EDGAR | — |
| 2025-11-17 | 0001193125-25-283873 | EDGAR | — |
| 2025-11-06 | 0001937653-25-000076 | EDGAR | — |
| 2025-09-02 | 0001193125-25-193351 | EDGAR | — |
102 total filings indexed. 77 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001937653 |
| Ticker | ZYME |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.zymeworks.com |
| Listed | 2017-04-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ZYME (~200 tokens, structured JSON with cryptographic provenance)